These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23811742)

  • 41. Recent Advances in Kawasaki Disease.
    Kim KY; Kim DS
    Yonsei Med J; 2016 Jan; 57(1):15-21. PubMed ID: 26632378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Development of diagnosis].
    Ogata S; Ishii M
    Nihon Rinsho; 2008 Feb; 66(2):301-6. PubMed ID: 18260329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.
    Loh ACE; Kua PHJ; Tan ZL
    Singapore Med J; 2019 Feb; 60(2):89-93. PubMed ID: 30009317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The different cutaneous presentations in three cases of Kawasaki disease as confounding factor of diagnosis.
    Demir AD; Goknar N; Uzuner S; Vehapoglu A; Saritas T; Oktem F
    J Pak Med Assoc; 2016 Sep; 66(9):1188-1190. PubMed ID: 27654745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual-probe pH monitoring for the assessment of gastroesophageal reflux in the course of chronic hoarseness in children.
    Kalach N; Gumpert L; Contencin P; Dupont C
    Turk J Pediatr; 2000; 42(3):186-91. PubMed ID: 11105615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis of incomplete Kawasaki disease].
    Tsuchiya K; Imada Y; Aso S; Sonobe T
    Nihon Rinsho; 2008 Feb; 66(2):321-5. PubMed ID: 18260331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease.
    Kanegaye JT; Van Cott E; Tremoulet AH; Salgado A; Shimizu C; Kruk P; Hauschildt J; Sun X; Jain S; Burns JC
    J Pediatr; 2013 Jun; 162(6):1259-63, 1263.e1-2. PubMed ID: 23305955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kawasaki disease and the pediatric gastroenterologist: a diagnostic challenge.
    Eladawy M; Dominguez SR; Anderson MS; Glodé MP
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):297-9. PubMed ID: 23085893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical features of children with recurrent Kawasaki disease: a Meta analysis].
    Luo G; Pan SL; Wang SB; DU ZH; Ji ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1306-1312. PubMed ID: 33328002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Atypical Kawasaki disease with acute cholestasis and early coronary involvement at onset in an adolescent].
    Vergine G; Di Napoli L; Bigucci B; Fabbri E; Viola L; Libertucci F; Testa P; Prandstraller D
    G Ital Cardiol (Rome); 2020 Feb; 21(2):152-156. PubMed ID: 32051639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnosis and management of Kawasaki disease.
    Royle J; Burgner D; Curtis N
    J Paediatr Child Health; 2005 Mar; 41(3):87-93. PubMed ID: 15790316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment.
    Almeida B; Gleeson P; Chawla K; Brogan P
    Br J Hosp Med (Lond); 2012 Feb; 73(2):C26-8. PubMed ID: 22504712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythema multiforme as first sign of incomplete Kawasaki disease.
    Vierucci F; Tuoni C; Moscuzza F; Saggese G; Consolini R
    Ital J Pediatr; 2013 Feb; 39():11. PubMed ID: 23406772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.
    Ko TM; Kuo HC; Chang JS; Chen SP; Liu YM; Chen HW; Tsai FJ; Lee YC; Chen CH; Wu JY; Chen YT
    Circ Res; 2015 Feb; 116(5):876-83. PubMed ID: 25605650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
    Giannouli G; Tzoumaka-Bakoula C; Kopsidas I; Papadogeorgou P; Chrousos GP; Michos A
    Pediatr Cardiol; 2013 Aug; 34(6):1476-81. PubMed ID: 23463134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Value of anti-neutrophil cytoplasmic antibody in diagnosis of Kawasaki disease].
    Jiang ZG; Liu L; Yang CY; Wu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):45-7. PubMed ID: 22289752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Presentation and Cardiovascular Outcome in Complete versus Incomplete Kawasaki Disease.
    Shivalingam G; Prashanth GP; Hebbal K; Aguiar R
    Indian Pediatr; 2017 Oct; 54(10):844-847. PubMed ID: 28699614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kawasaki disease: an update on diagnosis and treatment.
    Kuo HC; Yang KD; Chang WC; Ger LP; Hsieh KS
    Pediatr Neonatol; 2012 Feb; 53(1):4-11. PubMed ID: 22348488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kawasaki disease in monozygotic twins.
    Kottek A; Shimizu C; Burns JC
    Pediatr Infect Dis J; 2011 Dec; 30(12):1114-6. PubMed ID: 21796015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.